Zeheng Tan

机构：First Affiliated Hospital of Guangzhou Medical University, Guangzhou First People's Hospital, Guangzhou Medical University

发表论文 16 篇 · 总被引 89 次 · h-index 6

代表论文

• Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma (2022 · Frontiers in Immunology · 被引 26)
• Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation (2025 · Cancer Letters · 被引 14)
• ACOX2 Serves as a Favorable Indicator Related to Lipid Metabolism and Oxidative Stress for Biochemical Recurrence in Prostate Cancer (2024 · Journal of Cancer · 被引 13)
• Precision targeted melanoma therapy via cuproptosis/chemodynamic and chemotherapy: An engineering MCHS-CuMOF nanodelivery system (2025 · Biomaterials Advances · 被引 10)
• Metabolomic and Proteomic Analyses Unveil That Polyethylene Glycol–Polycaprolactone-Loaded Curcumin Nanoparticles Induce Mitochondrial Dysfunction and Metabolic Reprogramming to Suppress Melanoma Growth (2025 · ACS Applied Materials & Interfaces · 被引 7)
• N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification (2024 · International Immunopharmacology · 被引 6)